학술논문
THROWING BIOTECH ANOTHER TAX-CREDIT BONE.
Document Type
Article
Author
Source
Subject
*Tax credits
*Investors
*Small business finance
*Biotechnology industries
*
*
*
Language
ISSN
1090-4417
Abstract
The article reports that Jonathan Cohen, chief executive officer (CEO) Of 20/20 Gene Systems Inc., is working to take a piece of the annual 6-million U.S. dollar tax credit for investors in biotechnologies that received grants from the Small Business Innovation and Research (SBIR) program. A tax credit of 25% will be given to private equity investment in companies that have SBIR awards. Meanwhile, the Small Biotech Business Coalition (SBBC) is looking to increase the credit to 35% for the development of drugs and devices.